Parkinson's disease (PD) is one of most disabling disorders of the central nervous system. The motor symptoms of Parkinson's disease: shaking, rigidity, slowness of movement, postural instability and difficulty with walking and gait, are difficult to measure. When disease symptoms become more pronounced, the patient experiences difficulties with hand function and walking, and is prone to falls. Baseline motor impairment and cognitive impairment are probable predictors of more rapid motor decline and disability. An additional difficulty is the variability of the symptoms caused by adverse effects of drugs, especially levodopa.
INTRODUCTION
Parkinson's disease (PD) is a degenerative disorder of the central nervous system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain; the cause of this cell death is unknown. In the course of the disease, the most obvious symptoms are movement-related: tremor, rigidity, slowness of movement, postural instability and difficulty with walking and gait. The disease is more common in older people, with most cases occurring after the age of 50. PD, which affects 2% of the population above 65 years of age and 4% of those over 85 years, is one of the most frequent causes of physical disability. When the disease symptoms become more pronounced, the patient experiences difficulties with hand function and walking, and prone to falls.
The principles of diagnose of PD were created in 1992 by Hughes et al., and developed in 1999 by Gelb et al. The clinical course of PD varies from patient-to-patient.
To predict the rate of motor decline and increasing disability in early PD, Marras et al. (2002) conducted a systematic review of English-language and French-language literature cited in the MEDLINE database . The results of 13 studies were summarized qualitatively. The study methods were highly variable, particularly regarding the choice of outcome measure. Baseline motor impairment and cognitive impairment are probable predictors of more rapid motor decline and disability. A lack of tremor at onset and older age both appear to be predictive of increasing disability, but conflicting results exist for their association with the rate of change of motor impairment. Family history of PD does not appear to be prognostically important. The prognostic value of many other factors studied is uncertain owing to conflicting or unconfirmed results.
Clinimetrics in Parkinson`s Disease. Clinimetrics in PD is a particularly difficult task. The basic symptoms of PD: bradykinesia, propulsion, retropulsion, lateropulsion, demarche à petit pas, lack of arms co-movements, problems with handwriting (micrograph), muscle rigidity, and tremor, can scarcely be assessed. An additional difficulty is the variability of the symptoms caused by adverse effects of drugs, especially levodopa.
The oldest scale for PD was published in 1967 by Margaret Hoehn and Melvin Yahr, as the result of observation of 856 patients (Hoehn & Yahr, 1967; Opara, 1998 and 2012) . It distinguishes five stages of injury and disability, defined as five stages of progression of the disease, from unilateral damage without disorders as stage I, to stage V, when the patient is confined in a wheelchair or bed. To-date, this scale is the most commonly used worldwide, especially in multicentre studies.
In 1987, Fahn and Elton headed a task force which developed the Unified Parkinson's Disease Rating Scale (UPDRS) which consists of six integral parts. These are:
I -the state of intellectual and mood disorders; II -activities of daily living (separately for phase 'on' and 'off'); III -motor examination; IV -complications of treatment; V -stages of the disease; VI -self-assessment of independence using the SchwabEngland Scale.
The first three areas and part of the fourth are assessed in a five-point scale (0-4 points). In the third part (motor) UPDRS assesses the speech, facies, tremor in resting, tremor intentional, rigidity, rapid movements of the fingers, rapid hand movements, alternating movements, leg movements, getting up from a chair, posture, stability of posture, starting walking and bradykinesia. Scoring system: 0 point = no involvement; 1 = detectable disorders; 2 = moderate disorders; 3 = considerable disorders; 4 = no function or severe disorders. For assessment of balance, the Berg Balance Scale (BBS, 1992), Tinetti Balance and Gait Assessment Tool (1987), Brunel Balance Assessment (BBA, 2002), and many other scales are used (Opara, 2012; Tinetti, 1986 In the 21 st century, posturometric and stabilometric evaluation has developed rapidly, and has also been used for evaluation in balance training [Stożek et Patients with PD demonstrate deficits in motor learning as well as bidirectional interference (the performance of one task concurrently interferes with the performance of another task) during dual-task performance. Foreman et al. in a recent (2013) report presented the results of a pilot study in which they examined patients with PD, as well as neurologically healthy participants during concurrent performance of postural and speaking tasks. Seven persons with PD and 7 healthy age-matched and 10 healthy young control subjects were tested in a motion capture facility. Task performances were performed concurrently and recorded during 3 time periods (acquisition (beginning and ending), 48-hour retention, and 1-week retention). In conclusion, the lack of consistent changes in motor performance in any of the tasks, except in the healthy young group, suggests a decreased efficiency of motor learning in the age-matched and PD groups and argues for increased practice dosages during balance training. Marusiak et al. concluded in 2009 that compared to controls, PD patients exhibited a higher amplitude in the biceps and triceps brachii muscles and lower median frequency of the mechanomyographical (MMG) signals in the both tested muscles. However, no differences in the EMG amplitude and an increase of the EMG median frequency in the triceps brachii muscle of the PD group were observed. The MMG was not affected by physiological postural tremor, and can depict differences between PD patients and controls, which may suggest that it is a valuable tool for neuromuscular assessment for this condition.
Fernandez-Del-Olmo et al. (2013) in their study described the investigations of electromyography pattern and the reaction time during a wrist flexion movement in response to three different stimuli: a visual imperative stimulus, visual stimulus simultaneous with a non-startle auditory stimulus, and with a startle auditory stimulus. Their results suggest that the startle reaction effect for upper limb movements are unimpaired in PD patients, and has different characteristics than the effect of non-startle stimuli. Berardelli et al. (1986) studied rapid wrist flexion movements in a group of 10 patients with PD, compared with the same movements made by a group of 8 normal individuals. When the normal subjects made movements through 60 degrees, the first agonist burst of EMG activity in the wrist flexor muscles was longer and larger than that seen in movements of 15 degrees. They concluded that changes in the velocity of movements at a single joint are not a good reflection of the overall clinical state of patients with PD. King et al. (2013) were interested in which outcome measures are sensitive to exercise intervention and explored the effects of two different exercise programmes for improving mobility in patients with PD. Thirty-nine participants were randomized into either the Agility Boot Camp (ABC) or treadmill training; 4x/week for 4 weeks. Four of five variables at the structure/function level changed after exercise: turn duration (P = 0.03), stride velocity (P = 0.001), peak arm speed (P = 0,001), and horizontal trunk ROM during gait (P = 0.02). Most measures improved similarly for both interventions. The only variable that detected a difference between groups was postural sway in ABC group (F = 4.95; P = 0.03). The authors concluded that the outcome measures at ICF body structure/function level were most effective at detecting change after exercise, and revealing differences in improvement between interventions.
Recently, Klucken et al. (2013) developed a biosensorbased Embedded Gait Analysis using Intelligent Technology (eGaIT), which consist of accelerometers and gyroscopes attached to shoes that record motion signals during standardized gait and leg function. The results were confirmed in a second independent validation cohort (42 patients, 39 controls). eGaIT was able to successfully distinguish PD patients from controls with UPDRS-III classification rate of 81%. Table 3 contains the most commonly used tests for assessment of walking in Parkinson`s disease. Three-dimensional motion assessment of gait in PD. Mirek et al. (2007) used three-dimensional analysis of movement which allowed precise assessment of gait disorders among 32 PD patients (age range: 50-75) in I-III stages of the disease according to Hoehn-Yarr. They concluded that patients with PD differed significantly from the control group in all spatiotemporal parameters; they had a clearly lower cadence, walking speed and step length, and their time for single and double support was longer. Among kinematic parameters of gait, patients with PD had a reduced range of movement in the lower limbs joints. They began the double support phase earlier and their swing phase was delayed when compared to controls. The later stages of PD are characterized by altered gait patterns. Decreased arm swing has been described as an early sign of PD. Lewek et al. (2010) in 12 individuals with early PD (in 'off' state) and 8 controls, conducted gait analysis using an optically-based motion capture system. Twelve individuals with early PD (in 'off' state) and 8 controls underwent gait analysis using an optically-based motion capture system. Both groups had comparable gait velocities (p = 0.61), and there was no significant difference between the groups in the magnitude of arm swing in all walking conditions for the arm that swung more (p = 0.907) or less (p = 0.080). Strikingly, the PD group showed significantly greater arm swing asymmetry (asymmetry angle: 13.9 + or -7.9%), compared to the control group (asymmetry angle: 5.1 + or -4.0%; p = 0,003). Unlike arm swing magnitude, arm swing asymmetry unequivocally differed between people with early PD and controls. Morris et al. (2005) examined whether people with PD have a central amplitude regulation disorder using threedimensional (3-D) gait analyses to compare the effects of medication and attentional strategies on gait in 12 PD subjects and 12 matched comparison subjects. They found evidence for a centrally-mediated amplitude regulation disorder in PD.
Recently, Speciali and al. (2013) published a study in which 14 patients with idiopathic PD and 9 healthy subjects participated. All subjects walked under 2 conditions: free walking and dual task (DT) walking. Then the Gait Deviation Index (GDI), developed by Schwartz and Rozumalski in 2008, were computed, the results showed gait impairment during DT, a significant difference between groups regarding GDI and an interaction effect involving the group, side and task factors. Both groups were different, independent of interference and side, but interference was only different for the PD group. 
